3

OWNERSHIP DOCUMENT

Company: CRESCENT BIOPHARMA, INC.
Filed: August 26, 2019
Period of Report: August 15, 2019
Accession Number: 0000921895-19-002332

View Document ↗ View on SEC.gov ↗